Get started
Author

Esperanza Martín‐Sánchez

Observed names: E. Martin-Sanchez, E. Martín-Sánchez, Esperanza Martin-Sanchez, Esperanza Martin‐Sanchez, Esperanza Martín-Sánchez, Esperanza Martín-Sanchez, Esperanza Martín-Sánchez, Martín-Sánchez, Esperanza
Observed institutions: Universidad de Cantabria, University of the Basque Country, Universidad Pública de Navarra (UPNA), Research Institute Hospital 12 de Octubre, Spanish National Cancer Research Centre, Complejo Hospitalario de Navarra, Marqués de Valdecilla University Hospital, Hospital Universitario 12 De Octubre, Hospital Universitario Puerta de Hierro Majadahonda, Navarre Institute of Health Research, Instituto de Investigación Marqués de Valdecilla, Centro de Investigación Biomédica en Red, Navarrabiomed, Clinica Universidad de Navarra, Departamento de Salud, Centro de Investigación Biomédica en Red de Cáncer, Hospital Universitario Severo Ochoa, Centro de Investigación Médica Aplicada, Universidad de Navarra
ORCID: 0000-0002-8155-9185
Observed ORCID: 0000-0002-8155-9185
OpenAlex ID: A5086531116
PLCG1 mutations in cutaneous T-cell lymphomas
2014 · José P. Vaqué, Gonzalo Gómez-López, et al. · Blood · 229
NIK Controls Classical and Alternative NF-κB Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells
2013 · Lina Odqvist, Margarita Sánchez-Beato, et al. · Clinical Cancer Research · 56
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2022 · Rosalinda Termini, David Žihala, et al. · Clinical Cancer Research · 54
PDF
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
2020 · Saioa Mendaza, Ane Ulazia-Garmendia, et al. · International Journal of Molecular Sciences · 50
PDF
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
2017 · Esperanza Martín-Sánchez, Saioa Mendaza, et al. · Oncotarget · 37
PDF
NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
2014 · Lina Odqvist, Santiago Montes-Moreno, et al. · Modern Pathology · 30
PDF
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
2021 · Esperanza Martín-Sánchez, Juan José Garcés, et al. · Frontiers in Immunology · 28
PDF
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas
2012 · E. Martin-Sanchez, S. M. Rodriguez-Pinilla, et al. · Haematologica · 28
PDF
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
2021 · Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, et al. · Blood Cancer Journal · 23
PDF
PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases
2014 · Esperanza Martín-Sánchez, Lina Odqvist, et al. · PLoS ONE · 22
PDF
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix
2020 · Saioa Mendaza, Joaquín Fernández-Irigoyen, et al. · International Journal of Molecular Sciences · 21
PDF
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
2017 · Esperanza Martín-Sánchez, Saioa Mendaza, et al. · Clinical Epigenetics · 18
PDF
Immunologic characterization of COVID-19 patients with hematological cancer
2020 · Catarina Maia, Esperanza Martín-Sánchez, et al. · Haematologica · 17
PDF
Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix
2015 · Idoia Blanco‐Luquin, Rosa Guarch, et al. · Pathology International · 16
Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA
2016 · E. Martín-Sánchez, E. Pernaut-Leza, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 14
HDAC inhibitors induce cell cycle arrest, activate the apoptotic extrinsic pathway and synergize with a novel PIM inhibitor in Hodgkin lymphoma‐derived cell lines
2010 · Esperanza Martín‐Sánchez, Margarita Sánchez‐Beato, et al. · British Journal of Haematology · 14
PDF
A CD38 / CD3xCD28 trispecific T‐cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti‐ CD38 monoclonal antibodies
2024 · Aintzane Zabaleta, Laura Blanco, et al. · British Journal of Haematology · 10
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia
2024 · Esperanza Martín-Sánchez, Laura Blanco, et al. · Blood Advances · 10
Enhanced dynamic risk stratification of smoldering multiple myeloma
2026 · Floris Chabrun, Daniel E. Schwartz, et al. · Nature Medicine · 7
PDF
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis
2021 · Saioa Mendaza, David Guerrero-Setas, et al. · Biomedicines · 7
PDF
Biological and Clinical Significance of Undetectable Circulating Tumor Cells (CTCs) in Patients (Pts) with Multiple Myeloma (MM)
2023 · Juan-José Garcés, Rosalinda Termini, et al. · Blood · 6
A CD38/CD28xCD3 Trispecific T-Cell Engager (TCE) As a Potentially Active Agent in Multiple Myeloma Patients Relapsed and/or Refractory (RRMM) to Anti-CD38 Monoclonal Antibodies (mAbs)
2023 · Aintzane Zabaleta, Laura Blanco, et al. · Blood · 5
Immune biomarkers of increased infection risk in multiple myeloma
2026 · Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, et al. · Blood · 4
Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix
2021 · Saioa Mendaza, Joaquín Fernández-Irigoyen, et al. · Cancers · 4
PDF
Circulating tumor cells (CTCs) improve risk stratification according to the second revision of the international staging system (R2-ISS) and the ims-IMWG consensus genomic staging (CGS) in newly diagnosed multiple myeloma (NDMM): An analysis from the european CTC consortium.
2025 · Mattia D'Agostino, Esperanza Martin-Sanchez, et al. · Blood · 2
PDF
Works count: 110
Citation count: 725
H-index: 14
I10-index: 18
Year
Topic
Type